Product correctly added to cart.

(3beta,8xi,9xi,10xi,14xi,20xi,22S,23R,25xi)-11-oxo-17,23-epoxyveratraman-3-yl beta-D-glycero-hexopyranoside

CAS: 36069-05-3 - (3beta,8xi,9xi,10xi,14xi,20xi,22S,23R,25xi)-11-oxo-17,23-epoxyveratraman-3-yl beta-D-glycero-hexopyranoside

Formula:C33H49NO8

InChI:InChI=1S/C33H49NO8/c1-15-11-22-26(34-13-15)17(3)33(42-22)10-8-20-21-6-5-18-12-19(40-31-30(39)29(38)27(36)23(14-35)41-31)7-9-32(18,4)25(21)28(37)24(20)16(33)2/h5,15,17,19-23,25-27,29-31,34-36,38-39H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,22+,23+,25+,26-,27+,29-,30+,31+,32-,33-/m0/s1

InChI key:InChIKey=HYDDDNUKNMMWBD-VPLHBGEQSA-N

SMILES:O=C1C2=C(C)C3(OC4CC(C)CNC4C3C)CCC2C5CC=C6CC(OC7OC(CO)C(O)C(O)C7O)CCC6(C)C15

Sort by


See more categories

This search does not contain any category.

Found 4 products.

discount label

Pseudojervine

CAS:36069-05-3

Ref: 7W-GY7233

Undefined sizeTo inquire
Estimated delivery in United States, on Thursday 11 Apr 2024
discount label

Pseudojervine

CAS:36069-05-3

Ref: TM-TN2343

1mg94.00 €
2mg152.00 €
5mg260.00 €
10mg425.00 €
25mg688.00 €
50mgTo inquire
Estimated delivery in United States, on Thursday 11 Apr 2024
discount label

Pseudojervine

CAS:36069-05-3

Ref: BP-BP4502

5mg185.00 €
10mg324.00 €
20mg553.00 €
Estimated delivery in United States, on Monday 15 Apr 2024
discount label

Pseudojervine

CAS:36069-05-3

Ref: 3D-LBA06905

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 22 May 2024
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.